• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV 感染者肺气肿的发病机制和治疗管理。

Pathogenesis and management of emphysema in people with HIV.

机构信息

Division of Pulmonary and Critical Care Medicine, Weill Cornell Medical College, New York, USA.

Department of Genetic Medicine, Weill Cornell Medical College, New York, USA.

出版信息

Expert Rev Respir Med. 2023 Jul-Dec;17(10):873-887. doi: 10.1080/17476348.2023.2272702. Epub 2023 Nov 24.

DOI:10.1080/17476348.2023.2272702
PMID:37848398
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10872640/
Abstract

INTRODUCTION

Since early in the HIV epidemic, emphysema has been identified among people with HIV (PWH) and has been associated with increased mortality. Smoking cessation is key to risk reduction. Health maintenance for PWH and emphysema should ensure appropriate vaccination and lung cancer screening. Treatment should adhere to inhaler guidelines for the general population, but inhaled corticosteroid (ICS) should be used with caution. Frontiers in treatment include targeted therapeutics. Major knowledge gaps exist in the epidemiology of and optimal care for PWH and emphysema, particularly in low and middle-income countries (LMIC).

AREAS COVERED

Topics addressed include risk factors, pathogenesis, current treatment and prevention strategies, and frontiers in research.

EXPERT OPINION

There are limited data on the epidemiology of emphysema in LMIC, where more than 90% of deaths from COPD occur and where the morbidity of HIV is most heavily concentrated. The population of PWH is aging, and age-related co-morbidities such as emphysema will only increase in salience. Over the next 5 years, the authors anticipate novel trials of targeted therapy for emphysema specific to PWH, and we anticipate a growing body of evidence to inform optimal clinical care for lung health among PWH in LMIC.

摘要

简介

自艾滋病流行早期以来,人们已经在 HIV 感染者(PWH)中发现了肺气肿,并发现其与死亡率增加有关。戒烟是降低风险的关键。PWH 和肺气肿的健康维护应确保适当的疫苗接种和肺癌筛查。治疗应遵循针对普通人群的吸入器指南,但应谨慎使用吸入性皮质类固醇(ICS)。治疗的前沿领域包括靶向治疗。在 PWH 和肺气肿的流行病学和最佳护理方面存在重大知识空白,特别是在低收入和中等收入国家(LMIC)。

涵盖的主题

涉及的主题包括危险因素、发病机制、当前的治疗和预防策略以及研究前沿。

专家意见

在 LMIC 中,关于肺气肿的流行病学数据有限,而 COPD 导致的 90%以上的死亡都发生在这些国家,HIV 的发病率也最集中。PWH 的人口正在老龄化,年龄相关的合并症(如肺气肿)只会越来越突出。在未来 5 年内,作者预计会有针对 PWH 特有的肺气肿的靶向治疗的新试验,我们预计会有越来越多的证据来为 LMIC 中 PWH 的肺部健康提供最佳临床护理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91c/10872640/7397940f8f9c/nihms-1939837-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91c/10872640/ec8559eed2e2/nihms-1939837-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91c/10872640/9b3acaa31c4c/nihms-1939837-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91c/10872640/e17fa8a36314/nihms-1939837-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91c/10872640/7397940f8f9c/nihms-1939837-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91c/10872640/ec8559eed2e2/nihms-1939837-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91c/10872640/9b3acaa31c4c/nihms-1939837-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91c/10872640/e17fa8a36314/nihms-1939837-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91c/10872640/7397940f8f9c/nihms-1939837-f0004.jpg

相似文献

1
Pathogenesis and management of emphysema in people with HIV.HIV 感染者肺气肿的发病机制和治疗管理。
Expert Rev Respir Med. 2023 Jul-Dec;17(10):873-887. doi: 10.1080/17476348.2023.2272702. Epub 2023 Nov 24.
2
Chronic obstructive pulmonary disease in HIV.HIV 相关慢性阻塞性肺疾病。
Expert Rev Respir Med. 2021 Jan;15(1):71-87. doi: 10.1080/17476348.2021.1848556. Epub 2020 Nov 23.
3
COPD in People with HIV: Epidemiology, Pathogenesis, Management, and Prevention Strategies.HIV 感染者中的 COPD:流行病学、发病机制、管理和预防策略。
Int J Chron Obstruct Pulmon Dis. 2023 Nov 29;18:2795-2817. doi: 10.2147/COPD.S388142. eCollection 2023.
4
Effect of Human Immunodeficiency Virus on Lung Function and Structure: A Systematic Review and Meta-Analysis.人类免疫缺陷病毒对肺功能和结构的影响:一项系统评价和荟萃分析。
Ann Am Thorac Soc. 2025 Feb;22(2):274-284. doi: 10.1513/AnnalsATS.202404-384OC.
5
Incidence of Chronic Obstructive Pulmonary Disease in People With Human Immunodeficiency Virus and Their Parents and Siblings in Denmark.丹麦人类免疫缺陷病毒感染者及其父母和兄弟姐妹中慢性阻塞性肺疾病的发病率
J Infect Dis. 2022 Feb 1;225(3):492-501. doi: 10.1093/infdis/jiab369.
6
COPD, emphysema and the onset of lung cancer. A systematic review.COPD、肺气肿与肺癌发病。系统综述。
Cancer Lett. 2016 Nov 28;382(2):240-244. doi: 10.1016/j.canlet.2016.09.002. Epub 2016 Sep 22.
7
Association between asthma, chronic bronchitis, emphysema, chronic obstructive pulmonary disease, and lung cancer in the US population.美国人群中哮喘、慢性支气管炎、肺气肿、慢性阻塞性肺疾病与肺癌之间的关联。
Environ Sci Pollut Res Int. 2023 Feb;30(8):20147-20158. doi: 10.1007/s11356-022-23631-3. Epub 2022 Oct 17.
8
Combined Pulmonary Fibrosis and Emphysema (CPFE) Clinical Features and Management.肺纤维化合并肺气肿(CPFE)的临床特征和管理。
Int J Chron Obstruct Pulmon Dis. 2021 Jan 28;16:167-177. doi: 10.2147/COPD.S286360. eCollection 2021.
9
Brief Report: Alternative Pulmonary Function Measures of Emphysema in People With HIV.简报:HIV 感染者肺气肿的替代肺功能测量。
J Acquir Immune Defic Syndr. 2024 Nov 1;97(3):282-285. doi: 10.1097/QAI.0000000000003490.
10
Obstructive Lung Disease in HIV-Phenotypes and Pathogenesis.HIV 表型与发病机制中的阻塞性肺病。
Curr HIV/AIDS Rep. 2019 Aug;16(4):359-369. doi: 10.1007/s11904-019-00456-3.

本文引用的文献

1
The Pleiotropic Role of Vitamin K in Multimorbidity of Chronic Obstructive Pulmonary Disease.维生素K在慢性阻塞性肺疾病多种合并症中的多效性作用
J Clin Med. 2023 Feb 5;12(4):1261. doi: 10.3390/jcm12041261.
2
Discriminative Accuracy of the CAPTURE Tool for Identifying Chronic Obstructive Pulmonary Disease in US Primary Care Settings.用于识别美国初级保健环境中慢性阻塞性肺疾病的 CAPTURE 工具的判别准确性。
JAMA. 2023 Feb 14;329(6):490-501. doi: 10.1001/jama.2023.0128.
3
HIV Increases the Risk of Cigarette Smoke-Induced Emphysema Through MMP-9.
HIV 通过 MMP-9 增加香烟烟雾引起的肺气肿的风险。
J Acquir Immune Defic Syndr. 2023 Mar 1;92(3):263-270. doi: 10.1097/QAI.0000000000003125. Epub 2022 Nov 4.
4
Prevalence of emphysema in people living with human immunodeficiency virus in the current combined antiretroviral therapy era: A systematic review.当前联合抗逆转录病毒治疗时代人类免疫缺陷病毒感染者中肺气肿的患病率:一项系统评价。
Front Med (Lausanne). 2022 Sep 21;9:897773. doi: 10.3389/fmed.2022.897773. eCollection 2022.
5
Changes in lung function among treated HIV-positive and HIV-negative individuals: analysis of the prospective AGEIV cohort study.治疗后 HIV 阳性和 HIV 阴性个体的肺功能变化:前瞻性 AGEIV 队列研究分析。
Lancet Healthy Longev. 2021 Apr;2(4):e202-e211. doi: 10.1016/S2666-7568(21)00033-7.
6
Acute Exacerbations Are Associated with Progression of Emphysema.急性加重与肺气肿进展相关。
Ann Am Thorac Soc. 2022 Dec;19(12):2108-2111. doi: 10.1513/AnnalsATS.202112-1385RL.
7
Clinical Trial of Losartan for Pulmonary Emphysema: Pulmonary Trials Cooperative Losartan Effects on Emphysema Progression Clinical Trial.氯沙坦治疗肺气肿的临床试验:肺试验合作组织氯沙坦对肺气肿进展的临床试验。
Am J Respir Crit Care Med. 2022 Oct 1;206(7):838-845. doi: 10.1164/rccm.202201-0206OC.
8
Premature Aging of the Airway Epithelium in Chronic Obstructive Pulmonary Disease in People Living with HIV.HIV感染者慢性阻塞性肺疾病气道上皮的早衰
Am J Respir Crit Care Med. 2022 Jul 15;206(2):131-132. doi: 10.1164/rccm.202204-0743ED.
9
Bronchoscopic Lung Volume Reduction for Emphysema: Review and Update.支气管镜下肺减容术治疗肺气肿:综述与更新
Semin Respir Crit Care Med. 2022 Aug;43(4):541-551. doi: 10.1055/s-0042-1747938. Epub 2022 May 13.
10
Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Reaffirmation Recommendation Statement.慢性阻塞性肺疾病筛查:美国预防服务工作组重新确认推荐声明。
JAMA. 2022 May 10;327(18):1806-1811. doi: 10.1001/jama.2022.5692.